Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

PATH vs VRNS: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

PATH Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 7–3 Matrix Metrics)

PATH Overall Winner 6-Pillar Tally: PATH 4 – 2 VRNS Matrix Metrics: PATH 7 – 3 VRNS

As of Nov 16, 2026, UiPath, Inc. (PATH) is the stronger overall head-to-head candidate over Varonis Systems, Inc. (VRNS) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). PATH carries a Unified Composite Score of 58.3/100 (HOLD) at $13.24 (17.4x Forward P/E, 9.4% operating margin), whereas VRNS carries 51.3/100 (HOLD) at $48.99 (114.9x Forward P/E, -22.5% operating margin).

  • Technical & Structure Timing Caution: PATH is currently in a Weinstein Distribution regime near a flattening 50-day moving average and Breakdown options structure phase (RSI 47.4); meanwhile VRNS trades in a Markup technical trend (CONSOLIDATION options phase, RSI 55.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About PATH vs VRNS
PATH NYSE Head-to-Head Winner
UiPath, Inc.
Services-Prepackaged Software
$13.24
-0.19% 1D
Market Cap $6.8B
TTM Revenue $1.72B
Forward P/E 17.4x
Beta / 30D Vol 0.86β · 30% Vol
Unified Composite Score
58.3 / 100 HOLD
Tech 74.0 Fund 68.0 Flow 68.0 Mom 60.0
Weinstein Technical Phase Distribution · Trim / tighten stop
Price near a flattening SMA50 (slope -8.7%) with fading momentum, RSI 47
RSI-14: 47.4 · SMA20: $13.49 · SMA50: $13.38
VRNS NASDAQ
Varonis Systems, Inc.
Services-Prepackaged Software
$48.99
+0.11% 1D
Market Cap $5.7B
TTM Revenue $716M
Forward P/E 114.9x
Beta / 30D Vol 0.52β · 4% Vol
Unified Composite Score
51.3 / 100 HOLD
Tech 42.0 Fund 50.0 Flow 51.0 Mom 50.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (4.9% over 20 days), RSI 55
RSI-14: 55.0 · SMA20: $48.91 · SMA50: $48.11

6-Pillar Scorecard Institutional Category Breakdown (PATH 4 – 2 VRNS)

Columns: Metric · PATH · VRNS
1. Valuation Multiples PATH
Forward P/E 17.4x 114.9x
Trailing P/E 19.6x 142.9x
PEG Ratio 0.41x 7.38x
EV / Revenue 3.7x 8.2x
2. Growth & Scale VRNS
Revenue Growth (YoY) +13.4% +17.3%
Earnings Growth (YoY) N/A +0.0%
TTM Revenue (USD) $1.72B $716M
Market Cap $6.8B $5.7B
3. Profitability & Quality PATH
Gross Margin 82.6% 76.3%
Operating Margin 9.4% -22.5%
Net Profit Margin 21.0% -21.4%
Return on Equity (ROE) 20.0% -29.5%
4. Balance Sheet & Cash Flow PATH
Cash Generation (TTM) $363M $115M
Cash Flow Margin 21.1% 16.1%
Net Cash / Leverage $528M Net Cash $243M Net Debt (1.19x D/E)
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning VRNS
Options Structure Phase BREAKDOWN CONSOLIDATION
Current IV / %ile 50.3% (11th %ile) 12.5% (3rd %ile)
Put/Call OI Skew 0.49x (Call-Skewed) 0.18x (Call-Skewed)
OBV Trend / Tech Phase DISTRIBUTION · Distribution NEUTRAL · Markup
6. R&D & Supply-Chain Moat PATH
OpEx & R&D Intensity 73.2% of Rev ($1.26B) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Cyclical / Execution-Driven Positioning
Supply-Chain Role Software - Infrastructure Operator Software - Infrastructure Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: PATH (7) vs VRNS (3)
Institutional Metric PATH VRNS Criterion Row Edge
Market Capitalization
Scale
$6.8B $5.7B Larger Scale PATH
Trailing P/E Ratio
Valuation
19.6x 142.9x Lower Multiple PATH
Forward P/E Ratio
Valuation
17.4x 114.9x Lower Multiple PATH
Revenue Growth (YoY)
Growth
+13.4% +17.3% Higher Growth VRNS
Operating Margin (TTM)
Profitability
9.4% -22.5% Higher Margin PATH
Net Profit Margin
Profitability
21.0% -21.4% Higher Margin PATH
Return on Equity (ROE)
Capital Efficiency
20.0% -29.5% Higher ROE PATH
52-Week Range Position
Momentum
38% ($9–$20) 96% ($20–$50) Stronger Trend VRNS
Beta / 30D Volatility
Risk Regime
0.86β · 30% Vol 0.52β · 4% Vol Lower Realized Risk VRNS
Unified Institutional Score
Composite Signal
58.3 / 100 (HOLD) 51.3 / 100 (HOLD) Higher Composite PATH
Trailing 12M Revenue (USD)
Operating Scale
$1.72B $716M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
82.6% 76.3% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.41x PEG · 3.7x EV/Rev 7.38x PEG · 8.2x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$363M ($528M Net Cash) $115M ($243M Net Debt (1.19x D/E)) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon PATH +2.51 pp
PATH: +3.07% · VRNS: +0.56%
3M Horizon VRNS +27.06 pp
PATH: -14.99% · VRNS: +12.07%
6M Horizon VRNS +45.76 pp
PATH: +24.48% · VRNS: +70.24%
1Y Horizon VRNS +48.76 pp
PATH: -6.0% · VRNS: +42.76%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period PATH Revenue VRNS Revenue PATH Op. Margin VRNS Op. Margin Margin Leader
FY2019 N/A $250M N/A -29.9% VRNS
FY2020 $340M $290M -153.9% -26.8% VRNS
FY2021 $610M $390M -18.2% -25.3% PATH
FY2022 $890M $470M -56.1% -25.6% VRNS
FY2023 $1.06B $500M -32.9% -23.5% VRNS
FY2024 $1.31B $550M -12.6% -21.4% PATH
FY2025 $1.43B $620M -11.4% -23.5% PATH
FY2026 $1.61B N/A 3.5% N/A PATH

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
PATH BREAKDOWN
54d in phase · OBV DISTRIBUTION
Current IV 50.3%
IV Percentile 11th %ile
Put/Call OI Skew 0.49x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow DISTRIBUTION
Exact PATH Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
VRNS CONSOLIDATION
93d in phase · OBV NEUTRAL
Current IV 12.5%
IV Percentile 3rd %ile
Put/Call OI Skew 0.18x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact VRNS Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
PATH Moat Profile Scale & Operating Efficiency Moat
Software - Infrastructure Operator
Competes within the Software - Infrastructure value chain with $6.8B market capitalization and 9.4% operating margin.
OpEx & R&D Reinvestment 73.2% of Rev ($1.26B)
90D Engineering Disclosures 0 Published
VRNS Moat Profile Cyclical / Execution-Driven Positioning
Software - Infrastructure Operator
Competes within the Software - Infrastructure value chain with $5.7B market capitalization and -22.5% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ PATH vs VRNS Key Questions & Quantitative Answers

As of Nov 16, 2026, UiPath, Inc. (PATH) is the stronger overall head-to-head candidate over Varonis Systems, Inc. (VRNS) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Profitability & Quality, Balance Sheet & Cash Flow). PATH carries a Unified Composite Score of 58.3/100 (HOLD) at $13.24 (17.4x Forward P/E, 9.4% operating margin), whereas VRNS carries 51.3/100 (HOLD) at $48.99 (114.9x Forward P/E, -22.5% operating margin). Technical & Structure Timing Caution: PATH is currently in a Weinstein Distribution regime near a flattening 50-day moving average and Breakdown options structure phase (RSI 47.4); meanwhile VRNS trades in a Markup technical trend (CONSOLIDATION options phase, RSI 55.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

VRNS leads the Growth & Scale pillar: PATH posts +13.4% YoY revenue growth and N/A YoY earnings growth on $1.72B TTM revenue (82.6% gross margin, 9.4% operating margin), compared with VRNS at +17.3% YoY revenue growth and +0.0% YoY earnings growth on $716M TTM revenue (76.3% gross margin, -22.5% operating margin). Across the 8-period historical trajectory (FY2019 to FY2026), PATH cumulative revenue shifted +373.5% while VRNS shifted +148.0%. In operating R&D and SG&A reinvestment, PATH deploys 73.2% of Rev ($1.26B) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for VRNS.

PATH screens cheaper on headline valuation multiples. PATH trades at 17.4x Forward P/E, 19.6x Trailing P/E, 0.41x PEG, and 3.7x EV/Revenue (21.1% FCF margin), whereas VRNS trades at 114.9x Forward P/E, 142.9x Trailing P/E, 7.38x PEG, and 8.2x EV/Revenue (16.1% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against PATH (20.0% ROE) versus VRNS (-29.5% ROE) capital efficiency.

In options market volatility and institutional positioning, PATH carries 50.3% implied volatility (11th %ile, Compressed (<25th %ile)), a 0.49x (Call-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (0.86β · 30% Vol realized risk). By comparison, VRNS carries 12.5% implied volatility (3rd %ile, Compressed (<25th %ile)), a 0.18x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (0.52β · 4% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.